Respiratory pharmacology. Antiviral agents.
In summary, there are numerous clinically useful antiviral agents currently available, with many more investigational drugs on the horizon. The future of antiviral chemotherapy looks bright, and the principles behind successful therapy will remain the same. It is hoped that with the advent of effective therapy, improved rapid viral diagnosis and early treatment of patients will be possible to maximize beneficial effects.
D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015774:Ganciclovir / Q000031:analogs & derivatives*; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy; D007372:Interferons / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use; D012299:Rimantadine / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D000998:Antiviral Agents; D012299:Rimantadine; D012254:Ribavirin; D007372:Interferons; C045895:9-((2,3-dihydroxy-1-propoxy)methyl)guanine; D000547:Amantadine; D014740:Vidarabine; D015774:Ganciclovir; D000212:Acyclovir